Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2025 May 29;64(29):e202507532. doi: 10.1002/anie.202507532

Asymmetric Aziridination of Allylic Carbamates Using Ion‐Paired Rhodium Complexes and Extrapolation to C─H Amination of Phenethyl Carbamates

Arthur R Lit 1,+, Shotaro Takano 1,+, Christian Zachau 1, Ioana Băltărețu 1, Robert J Phipps 1,
PMCID: PMC12258697  PMID: 40364763

Abstract

Aziridination of alkenes is an important route to chiral nitrogen‐containing building blocks. Here, we report that carbamate‐functionalized allylic alcohols undergo highly enantioselective aziridination using achiral dimeric Rh(II, II) complexes that are ion‐paired with cinchona alkaloid‐derived chiral cations. The aziridine‐containing products are amenable to a variety of further reactions to generate useful groupings of functionality. Furthermore, we show that the carbamate group is effective for directing highly enantioselective benzylic C─H amination when it is appended to phenethyl alcohols. Intermolecular C─H amination of phenethyl alcohol derivatives has proven highly challenging to achieve asymmetrically yet it gives rise to valuable β‐amino alcohols. Both processes result in rapid access to versatile, highly enantioenriched small molecule building blocks for synthesis and highlight the effectiveness and generality of this chiral cation‐based strategy for asymmetric catalysis. We report studies that probe important structural features of the chiral cation and demonstrate that the ion‐paired complexes can be formed from their individual components without a separate isolation step.

Keywords: Asymmetric catalysis, Aziridination, Chiral cations, Nitrenoid, Rhodium


Aziridination of alkenes is an important route to chiral nitrogen‐containing building blocks. We report that carbamate‐functionalized allylic alcohols undergo highly enantioselective aziridination using achiral dimeric Rh complexes ion‐paired with cinchona alkaloid‐derived chiral cations. Furthermore, the carbamate group is effective for directing highly enantioselective benzylic C─H amination when appended to phenethyl alcohols.

graphic file with name ANIE-64-e202507532-g006.jpg

Introduction

Aziridination is a fundamentally important transformation for the introduction of nitrogen atoms into small molecules, enabling their conversion into a variety of building blocks.[ 1 , 2 ] Serving as versatile intermediates, the aziridines can be manipulated to introduce various functional groups with vicinal relationship to the nitrogen, often with high regio‐ and stereoselectivity.[ 3 , 4 , 5 , 6 ] Therefore, the development of enantioselective aziridination methods is paramount to realizing the potential of this functional group for the synthesis of chiral nitrogen‐containing molecules.[ 7 , 8 , 9 , 10 , 11 , 12 , 13 ] Although aziridines are often described as the nitrogen equivalent of epoxides, enantioselective methods for their synthesis and manipulation are less advanced compared to their extensively studied oxygen counterparts. This is primarily because the preparation of chiral aziridines usually demand mechanistically distinct strategies that differ from those used in asymmetric epoxide synthesis, making it challenging to directly apply key advancements from asymmetric epoxidation to asymmetric aziridination.[ 14 ] Nevertheless, great advances have been achieved, which include pioneering reports that harness transition metal catalysts to mediate nitrene transfer to alkenes,[ 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 ] metal‐carbenoid insertion into imines,[ 30 , 31 , 32 , 33 , 34 ] organocatalyzed methods involving alkenes conjugated with carbonyl groups,[ 11 ] as well as significant progress in biocatalysis.[ 35 , 36 ] To highlight recent advances, Darses, Sircoglou, Dauban and co‐workers in 2022 disclosed a highly enantioselective intermolecular aziridination using Rh(II, II) tetracarboxylate complexes bearing chiral carboxylates.[ 37 ] More recently, two independent reports on the use of chiral (Cp)*Rh(III) complexes in the asymmetric aziridination of terminal unactivated alkenes have emerged from the Wang group and the collaborative effort of the Baik and Blakey groups.[ 38 , 39 ]

We have become interested in the challenge of enantioselective aziridination of allylic alcohols, in analogy with the Sharpless Asymmetric Epoxidation.[ 40 , 41 , 42 ] Considering the impact of the latter in asymmetric synthesis, it is notable that an aza‐equivalent remains undeveloped (Figure 1a).[ 43 ] A number of studies have demonstrated that directed aziridination can occur in allylic alcohols and related substrates, but this has only been harnessed for control of diastereoselectivity[ 44 , 45 , 46 , 47 ] or site‐selectivity,[ 48 , 49 , 50 ] not enantioselectivity. We recently developed a family of ion‐paired Rh(II, II) complexes which are doubly anionic and paired with two cinchona alkaloid‐derived chiral cations. These catalysts were used in benzylic C─H amination and aziridination of substrates that bear a pendant primary alcohol, which we believe engages in hydrogen bonding with the sulfonate group on the ligand to provide organization at the transition state for nitrene transfer (Figure 1b, right, for aziridination).[ 51 , 52 , 53 ] One of the constraints was the minimum chain length that could be tolerated between the reaction site (benzylic position for C─H amination or alkene for aziridination) and the alcohol directing group. In our first report on aziridination, we were able to achieve excellent results on a broad range of differentially substituted homoallylic alcohols, but enantioselectivity dropped to non‐useful levels with the shorter‐chained allylic alcohols (Figure 1b, left).[ 52 ] Subsequently, we were able to tailor the design of the ligand to successfully accommodate certain allylic alcohols with high ee, a limitation being that the scope was restricted to trisubstituted, non‐styrenyl alkenes.[ 53 ] Although this was a step forward, substantial scope for improvement remained. At the same time, we developed benzylic C─H amination using the same complexes and were able to achieve excellent results on hydrocinnamyl alcohols and those with longer chains between the hydroxyl and the arene. However, phenethyl alcohols gave extremely poor reactivity which we attribute to electronic deactivation of the benzylic position combined with the chain between the alcohol and the site of reaction being too short for effective catalyst direction (Figure 1c). This limitation was disappointing because benzylic C─H amination of phenethyl alcohols gives rise to β‐amino alcohols, which are important building blocks in a range of applications.[ 54 , 55 , 56 ] Towards this goal, several enantioselective aminations of phenethyl alcohol derivatives have been disclosed, including using metal nitrene chemistry, but all operate in an intramolecular manner.[ 57 , 58 , 59 , 60 , 61 , 62 , 63 ] Very recently, Zhou and co‐workers disclosed a rare intermolecular C─H amination of benzylic C─H bonds, including a protected phenethylalcohol, using chiral copper catalysts.[ 64 ] Nevertheless, intermolecular, asymmetric amination of phenethylalcohol derivatives to give protected β‐amino alcohols remains extremely challenging.

Figure 1.

Figure 1

Background and relevant precedent in nitrene transfer using ion‐paired catalysts.

In parallel studies, we discovered that tertiary amides were highly effective “directing groups” for enantioselective C─H amination using our ion‐paired catalysts (Figure 1d, previous work).[ 65 ] This was initially surprising as tertiary amides are hydrogen bond acceptors rather than donors. Their effectiveness implied that a different type of interaction with the catalyst complex was in operation compared to the sulfonate‐alcohol hydrogen bonding interaction we had previously envisaged (Figure 1b). Based on control experiments using an O‐methylated cation we speculate that this could potentially occur through hydrogen bonding of the substrate amide with the free hydroxyl of the chiral cation and the α‐ammonium protons.[ 65 ] We herein disclose that carbamate‐protected allylic alcohols constitute excellent substrates for asymmetric aziridination. Furthermore, the carbamate group can also be used to direct highly enantioselective benzylic C─H amination on phenethyl alcohol derivates to give β‐amino alcohols (Figure 1d, this work). In both substrates, the incorporation of a carbamate allows us to overcome limitations of our previous protocols whereby the shortest chain lengths of alcohols were incompatible.

Results and Discussion

Previous efforts at allylic alcohol aziridination using our ion‐paired catalysts had resulted in poor enantioselectivity on styrenyl substrates (45% ee, Figure 1b, lower left).[ 52 ] We therefore selected the cis isomer of cinnamyl alcohol for evaluation and converted it to the corresponding carbamate 1a with the intention that the carbonyl may engage in productive interactions with the chiral cation. In previous studies on the amide‐directed C─H amination, we had found that substoichiometric amounts of C6F5I(OTFA)2 as a weak acid additive were crucial for both high yield and enantioselectivity (Figure 2).[ 65 ] The origin of this effect has not been definitively established, but we speculate that protonation of the basic quinoline nitrogen of the chiral cation may change the conformation of the cation leading to higher enantioselectivity, and separate mechanistic studies showed that removal of this basic nitrogen from the cation was detrimental to enantioselectivity in the alcohol‐directed nitrene transfer.[ 53 ] Aziridination using 1 mol% of pyridine‐ligated Rh complex Rh2(A1)2•(B1)2•(Pyr)2 with 10 mol% C6F5I(OTFA)2 afforded the desired aziridine 3a as observed by 1H‐NMR analysis of the crude reaction mixture. This was heated in aqueous acetonitrile to give 68% NMR yield of cyclic carbonate 4a in 88% ee as a single diastereomer (Figure 2, entry 1). Whilst the aziridine 3a is stable to isolation (see later), we found it most convenient for optimization purposes to analyse at the cyclic carbonate stage. Importantly, this two‐step aziridination/cyclization protocol constitutes a formal enantioselective, diastereoselective and regioselective oxyamination of the alkene, which remains as a challenging transformation.[ 36 , 66 , 67 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 ] Omission of C6F5I(OTFA)2 was found to be detrimental to both yield and ee, in line with our previous observations (entry 2). As a control, we evaluated the reaction with the non‐pyridine‐ligated catalyst in the presence and absence of the C6F5I(OTFA)2 additive, but this also proved detrimental to reactivity and enantioselectivity (entries 3 and 4).[ 78 ] We also evaluated the trans isomer of 1a, which gave poor yield and ee, as well as an NH variant of 1a lacking the N‐Me group, which completely shut down aziridination reactivity (see SI for details). The poor performance of the trans‐styrenyl substrate is consistent with our prior observations in alcohol‐directed aziridination and suggest that this geometry of styrenyl substrate results in a very poor fit in the chiral pocket provided by the chiral cation, relative to the cis‐isomers. We also evaluated a substrate in which the carbamate is derived from morpholine rather than N‐methylaniline but found that the yield of aziridination/cyclization was poor and amination on the morpholine, adjacent to nitrogen, predominated (see SI for details). We subsequently evaluated catalysts that had different geminal cyclic substituents on the anionic Rh(II, II) dimers (A2A4), but in all cases the ee was unimproved (entries 5–7). Having identified the archetypal gem‐dimethyl complex A1 as the optimal rhodium scaffold, we evaluated four further cations bearing different benzylating groups on the quinuclidine nitrogen (B2B5). This revealed that two (B3 and B5) gave marginally improved enantioselectivities over B1 (entries 8–11), and with B5 the product could be isolated in high yield and 91% ee (entry 11). Neutral hydrolysis of 4a, followed by treatment with base furnished the rearranged carbamate demethoxy‐4‐epi‐cytoxazone, from which the absolute configuration was assigned by comparison with the literature (see SI).[ 79 ] Several different aminating agents were evaluated and were shown to be competent, including Tces, but the perfluorinated aminating agent indicated gave slightly higher selectivity (see SI for details).

Figure 2.

Figure 2

Optimization of the tandem aziridination/cyclization reaction of allylic carbamate 1a. [a] Yields determined from crude 1H‐NMR with 1,2‐dimethoxyethane as an internal standard. Values in parentheses correspond to isolated values. [b] ee was determined by chiral SFC analysis.

Before evaluating the full reaction scope with respect to arene substitution, we carried out a preliminary survey of three substrates with three different catalysts bearing cations B1, B3 and B5. The solubility properties of the B5‐containing complex were found to be poor at low temperatures, giving reproducibility issues. Over the three substrates tested, the B1‐containing complex proved to be reliable, with 2 mol% catalyst loading preferable (see SI for details). Therefore, the full scope of the reaction was explored using Rh2(A1)2•(B1)2•(Pyr)2 and we elected to cyclize the aziridine intermediates by post‐reaction heating to give carbonate products 4 as single diastereomers (Scheme 1). We were pleased to find that a variety of ortho‐ substituents were accommodated, including isopropyl (4b), methoxy (4c), fluoro (4d) and methyl (4e). Meta‐substituents included a Boc‐protected amine (4f), several electron donating groups (4 g, 4 h), a bromide (4i) and an ester (4j). Similar tolerance was also observed at the para position and this encompassed dichloro (4k), tert‐butyl (4l), trifluoromethoxy (4m), chloro (4n) and trifluoromethyl (4o) substituents. Isomeric naphthyl groups (4p, 4q) gave high ee although the 1‐naphthyl isomer gave a low yield (4q). We demonstrated the effectiveness of several heterocycles including a thiophene (4r) and an indole (4s), and showed that the antipode (ent4a) could be readily obtained using the complex containing diastereomeric cation C1, which is derived from quinine following removal of the vinyl group.[ 52 ] We also investigated the feasibility of operating the reaction in kinetic resolution mode and tested two racemic substrates (1t and 1u), each bearing an alkyl substituent on the allylic carbon. With methyl‐substituted 1t, the kinetic resolution worked successfully to give aminated product 4t in 36% yield and 97% ee. The recovered starting material (R)‐1t was isolated in 40% yield and 94% ee. With isopropyl‐substituted 1u, the reaction appeared slower, presumably due to the greater steric hindrance around the alkene, such that the product 4u was obtained in a lower yield but with excellent 91% ee.

Scheme 1.

Scheme 1

Scope for the enantioselective aziridination of cis‐styrenyl allylic carbamates 1. Yields and ee values correspond to isolated values. [a] Reaction performed with catalyst Rh2(A1)2•(B5)2•(Pyr)2 (1 mol%). [b] Reaction performed at −25 °C. [c] Reaction performed with Rh2(A1)2•(B1)2•(Pyr)2 (1 mol%). [d] Reaction performed with Rh2(A1)2•(C1)2•(Pyr)2 (2 mol%). [e] Reaction performed with Rh2(A1)2•(B1)2•(Pyr)2 (3 mol%) and sulfamate ester 2a (1.5 equiv.) at −10 °C.

We demonstrate that the aziridine intermediate is isolable, if desired (Scheme 2). In this case (using the complex containing cation B3), the isolated yield of the aziridine was significantly higher than the NMR yield obtained after cyclization (Figure 2, entry 9), suggesting that some material loss may occur during cyclization (the ee value was consistent). This particular aziridine was sufficiently stable for full characterization. The aziridine intermediates leading to para‐chloro‐substituted 4n and para‐CF3‐substituted 4o could also be isolated with ee values matching those of cyclized products 4n and 4o. Whilst crude NMR yields were between 60% and 70% the isolated yields were lower in these cases, which we believe is due to partial decomposition on silica (see SI). These aziridines also proved to be unstable on storage and would be best used in immediate further derivatization (see later) or potentially telescoped from the crude reaction mixture. We also attempted to isolate the aziridine leading to thiophene‐containing 4r, which was present in the crude reaction mixture, but found this was insufficiently stable on silica. To demonstrate the breadth of possible further transformations, we intercepted 3a in a variety of other processes (Scheme 2). Ring opening with azide afforded the diaminated products 5 and 6 with complete enantiospecificity, bearing differentially protected amines, allowing for possible orthogonal deprotection/functionalization. Furthermore, subjecting the aziridine to hydrogenation conditions enabled a formal hydroamination process of the alkene to be achieved (7). Treatment of the aziridine with HCl furnished the highly functionalized carbamate 8, which is proposed to arise from aziridine ring‐opening with the pendant carbamate, followed by chloride attack of the resulting cationic intermediate. Specifically, transformation into 8 significantly increased the functional and stereochemical complexity from the starting material 1a. Together, this selection of transformations illustrates the versatility of the aziridine product functionalized with a pendant carbamate.

Scheme 2.

Scheme 2

Isolation and synthetic elaboration of aziridine 3a.

We next carried out experiments to explore the impact of structural features of the cinchona alkaloid‐derived cation by knocking them out in a systematic manner, an approach we previously applied to the alcohol‐directed C─H amination and aziridination (Scheme 3a).[ 53 ] Cation B6 is a simplified version of the optimal cation, which lacks the quinuclidine ethyl group, the quinoline methoxy group and in which the quinoline nitrogen has been replaced with a methine unit to form a naphthalene. The complex containing B6 gave extremely poor ee in the aziridination/cyclization at only 23%. Systematically restoring the chiral cation features proved fascinating: addition of the quinoline nitrogen (cation B7) boosted ee significantly to 67%, its importance in line with our prior observations in the alcohol‐directed system. Returning the methoxy to the quinoline gave another increase, allowing 88% ee to be obtained using cation C1 (the antipode of 4a was produced in this case due to C1 having the opposite aminoalcohol configuration to the other cations). Return of the quinuclidine ethyl group in cation B1 adds only a 3% ee, indicating minimal importance. Given the evident importance of the quinoline nitrogen, we evaluated cation B8, which possesses an n‐butyl group at the quinoline C2 position. If binding of the quinoline nitrogen to the Rh catalyst was important then this feature would be expected to impact binding and potentially also ee. However, B8 gave practically identical results to the optimal B1, suggesting that the quinoline nitrogen is not operating in this way. We next evaluated cation B9 in which the free hydroxyl of the alkaloid is O‐methylated. Complexes containing this cation had given very poor outcomes in our previous studies when evaluated on the alcohol directed C─H amination and aziridination[ 53 ] as well as the amide‐directed C─H amination, implying a crucial role of this feature in organization at the transition state in those cases.[ 65 ] Remarkably, this cation proved to be just as effective as B1 here and actually increased ee to 95% (compared with 91% for B1), favouring the same major enantiomer of cyclized product 4a. This is a striking divergence compared with our previous observations and makes it clear that hydrogen bonding of the catalyst hydroxyl to the carbamate carbonyl cannot be an important factor in the high selectivity obtained. Using epimeric cation B10, which possesses a stereochemically inverted secondary alcohol, was detrimental, giving the opposite enantiomer of 4a in a relatively low −39% ee. Overall, as the quinoline nitrogen proves crucial, we suspect that a change in conformation of the cation could be occurring upon protonation in the presence of the acid‐releasing additive C6F5I(OTFA)2, as we have previously suggested in other systems.[ 53 , 65 ] Evaluating the O‐methylated cation in the absence of the C6F5I(OTFA)2 additive also gave a reduced ee (50% vs. 95%), indicating a consistent trend. Another possibility we considered is that the trifluoroacetic acid released from the additive engages in hydrogen bonding with the substrate carbamate group, resulting in a buildup of positive charge on the latter and enabling it to engage in electrostatic interactions with the catalyst sulfonate group. In such a scenario, an amide instead of a carbamate might be expected to be superior since an amide should be a stronger hydrogen bond acceptor.[ 80 ] However, evaluation of the directly analogous amide substrate showed this not to be the case as ee was reduced to 71% (9, vs. 91% for carbamate, Scheme 3b). At present, the exact nature of the interaction of the carbamate group with the catalyst in this complex multicomponent system remains elusive. Additionally, we carried out a control experiment where we used Rh2(esp)2 (2 mol%) as the catalyst under the optimized conditions with the optimal chiral cation B1 (4 mol%) added as its bromide salt. This resulted in only 22% ee, demonstrating the crucial importance of the attractive ion pairing interaction between the two components (Scheme 3c).

Scheme 3.

Scheme 3

Investigation of impact of cation structure on selectivity, assessment of amide directing group and disconnection of cation and Rh complex. [a] Antipode of 4a obtained due to C1 having the opposite aminoalcohol configuration compared with the others.

Given the effectiveness of the carbamate group in directing aziridination, we speculated whether it might also be a proficient directing group for Rh‐catalyzed C─H amination.[ 12 , 57 , 60 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 ] As described above, previous attempts using our ion‐paired catalysts with simple phenethyl alcohol resulted in trace reactivity (Figure 1c). We hoped that by transforming the alcohol into a carbamate, productive interaction with our ion‐paired catalyst may be restored and that the electronic challenges of the C─H insertion step may be overcome. This was evaluated on substrate 10a, and after brief optimization, we were very pleased to obtain high yield and ee (96%) of the desired amination product 11a (Scheme 4a). One optimization point to note was to use an N‐ethyl carbamate, instead of N‐methyl due to a minor by‐product (∼10%) resulting from amination of the N‐alkyl group of the carbamate.[ 93 , 95 ] This proved particularly troublesome in the case of the N‐methyl substrate as it co‐eluted with the desired product; in contrast, switching to N‐ethyl facilitated separation. Additionally, switching the aminating agent to one possessing a less fluorinated chain (2b, Pfps‐NH2) gave slightly higher yields. We also evaluated a morpholine‐containing carbamate but here C─H amination occurred exclusively on the morpholine portion, adjacent to nitrogen (see SI for full details). Similar to the aziridination, the antipode (ent11a) could also be obtained using the complex containing diastereomeric cation C2. At this stage we also evaluated the complex containing the O‐methylated cation B9, which had given superior ee compared with B1 in the aziridination (Scheme 3a). Here it gave 11a in 49% isolated yield and 94% ee—only slightly lower than B1, further demonstrating that in these carbamate‐containing substrates the free hydroxyl of the alkaloid is not playing an important organizational role. We proceeded to evaluate the enantioselective C─H amination of various carbamate‐protected phenethyl alcohols. Halogens, donating and withdrawing groups were successfully incorporated at para (11b11g), meta (11h11l) and ortho (11m11o) positions of the phenyl ring. It is noticeable that when the electron density on the aromatic ring is reduced, reactivity is also reduced, thus impacting yield (e.g., 11g, 11l). Although this was anticipated, we nevertheless found it remarkable that product was still obtained in these cases, given the proximity of the electron‐withdrawing carbamate group to the C─H bond undergoing insertion. To illustrate the profound effect on chemoselectivity of our ion‐paired catalysts, we struggled to get any of the desired racemic amination products for many substrates using Rh2(esp)2, which gave N‐ethyl amination as the major product in all cases. We were able to incorporate both regioisomers of thiophene into the substrate, giving excellent ee outcomes in products 11p and 11q. The carbamate derived from indan‐2‐ol also gave the corresponding product 11r in good yield as a single diastereomer. In this case, the ee was reduced to 72%, potentially due to the restricted conformational freedom of the substrate, which may hinder optimal interactions with the chiral cation at the transition state for C─H amination. As in the aziridination, a kinetic resolution substrate bearing a methyl group adjacent to oxygen performed very well in terms of selectivity, delivering 99% ee for 11s and highlighting the potential of this chemistry for accessing elaborately substituted chiral β‐amino alcohols. Finally, we demonstrate that both functional groups on the reaction product 11a could be readily and independently manipulated through either removal of the carbamate to give 12 [ 64 ] or removal of the Pfps group[ 93 ] to give 13 (Scheme 4b). The enantiopurity of 13 was preserved following analysis of the Boc‐protected derivative 14. The absolute configuration was determined by comparing 12 with an independently synthesized sample. Given the excellent reactivity that the carbamate directing group conferred in these substrates, we also evaluated a substrate bearing a linear aliphatic chain to determine whether amination on non‐activated aliphatic C─H bonds may be achievable using our catalyst. Unfortunately, no amination on the chain was observed, with amination only occurring on the methyl group of the amide. This reflects the much lower reactivity of these non‐activated C─H bonds with the rhodium nitrenoid (see SI for details).

Scheme 4.

Scheme 4

Scope for the enantioselective C─H amination of carbamate‐protected phenethyl alcohols 10. Yields and ee values correspond to isolated values. [a] Reaction performed with catalyst Rh2(A1)2•(C2)2•(Pyr)2 (2 mol%).

Returning to aziridination, since cis‐styrenyl allylic carbamates proved to be an effective class of alkenes, we aimed to explore the compatibility of various alkene substitution patterns with our reaction system. As an initial exploration, we tested one of the optimal catalysts on exo‐styrene 15a, trisubstituted prenol‐derived 15b and cis non‐styrenyl 15c (Scheme 5a). Unfortunately, the ee outcomes were poor and we resolved to examine more structurally diverse chiral cations, in the hope that a more fundamental change to the structure might provide a solution. Accordingly, we assembled a collection of cations (Scheme 5c) that included two cupreidine‐derived examples (B11 and B12 with the methoxy group on the quinoline demethylated); variants where the hydroxyl group of the alkaloid is replaced with alternative hydrogen bond donors such as urea (C4, C7), thiourea (C5), squaramide (C6) or amide (C8); and urea derivatives with inverted stereochemistry at C9 of the alkaloid (epiC4 and epiC7). Finally, BINOL‐derived phosphonium (D1)[ 96 ] and ammonium (D2)[ 97 ] cations developed by Maruoka were included to provide non‐cinchona examples. One of the potential advantages of using ion‐paired catalysts is that one can imagine a combinatorial approach to catalyst screening if they can be reliably formed in situ without tedious isolation. If viable, this would allow rapid exploration of a wider range of ion‐paired catalysts than would realistically be possible if the catalysts all had to be prepared and isolated discretely. In important prior work, Ooi and co‐workers demonstrated the in situ pairing of achiral ammonium phosphines with chiral phosphate anions to identify the optimal catalyst for the palladium‐catalyzed asymmetric allylic alkylation of benzo[b]thiophen‐2(3H)‐ones.[ 98 ] We sought to emulate aspects of that study, as well as incorporate mass spectrometry as a means to determine ee values from crude reaction mixtures using selected ion‐monitoring (SIM). This novel enantioselectivity assay method was recently shown in reports by Jacobsen, Kwan and co‐workers,[ 99 ] as well as Watson, Kelly, Sampson and collaborators,[ 100 ] to be reliable for high‐throughput asymmetric catalysis campaigns. We were keen to explore this assay method in order to make ee analysis of the crude reaction mixtures potentially more reliable and also to overcome the issue of a lack of UV chromophores in 16b and 16c (two different analytical methods were used to determine ee for 16a16c, see Scheme 4a). In particular, the enantiomers of 16c did not separate using GC‐FID conditions and necessitated further derivatization to install a chromophore for ee determination by SFC. After considering factors highlighted in the previous reports that can affect accuracy, we were able to use SIM‐MS analysis to obtain ee values for 16a16c that were broadly in line with those obtained through conventional means (Scheme 5b, inset table, top row). Continuing with the SIM‐MS analysis, after some experimentation we developed a protocol for rapid formation of the ion‐paired catalysts, which gave similar ee outcomes for original optimization substrate 1a and new substrates 15a15c when compared with the preformed complex. In this protocol the Rh dimer is protonated on Amberlite IRC120 acidic resin to give Rh2(A1)2•(H)2, which is stirred with four relative equivalents of the bromide salt of the chiral cation in methanol for 2.5 h (Scheme 4b, above reaction arrow). After removal of the solvent under vacuum, the remaining reaction components were added as normal. The ee outcomes for all four substrates were very similar to that using the preformed complex, providing satisfactory validation of the procedure (Scheme 5b, inset table, second row). Prior to this, we attempted true in situ generation of the catalysts in 1,3‐DFB prior to the addition of the rest of the reagents, but found this to be unreliable, suggesting that a pre‐stir step in methanol was required to enable formation, prior to solvent exchange. With confidence in both the ion pair formation and the SIM‐MS analysis, we proceeded to evaluate all the collected cations against the three new substrates (15a15c) as well as 1a using this protocol. The results were disappointing as none of the cations was able to provide high ee on the new substrates. For 1a, moving away from the natural structure of the alkaloid was clearly detrimental. The only significant ee value obtained was with the pseudoenantiomeric C3, which is derived from dihydroquinine. This gave the opposite enantiomer of 4a but in lower ee than with B3, indicating that C3 is a less effective pseudoenantiomer for B3. This “uneven efficiency” had been previously observed using preformed ion‐paired catalysts (thus prompting us to use the desvinylquinine‐derived cation to access the product antipode) and serves as a useful marker to give confidence in the protocol used for both the catalyst formation protocol and SIM‐MS analysis. Despite the lack of positive results obtained on the broader substrates, we believe that this demonstration of the rapid ion‐pairing protocol combined with SFC‐SIM‐MS ee analysis adds value for those looking to potentially exploit this or related methodology for high‐throughput optimization in asymmetric catalysis.

Scheme 5.

Scheme 5

Evaluation of alkene substitution patterns using rapid formation without isolation of diverse ion‐paired catalysts and analysis using SIM‐MS (selected ion monitoring – mass spectrometry). [a] Reaction performed with preformed ion‐paired catalyst Rh2(A1)2•(B3)2•(Pyr)2 (1 mol%).

Conclusion

We have demonstrated the highly enantioselective aziridination of carbamate‐protected cis‐styrenyl allylic alcohols. The aziridine intermediate is amenable to a host of valuable transformations. We have further shown that appending a very similar carbamate group onto phenethyl alcohols enables benzylic C─H amination to occur to form highly enantioenriched β‐amino alcohol derivatives. Both transformations had not been feasible using alcohol directing groups and the scope of enantioselective nitrene transfer using our ion‐paired Rh catalysts has been significantly broadened with these findings. We also demonstrate that our ion‐paired catalysts can be formed without isolation of the discrete catalyst from individual salts and that ee can be analysed using mass response in selected ion‐monitoring. These findings lay a foundation for high throughput experimentation to be applied to catalyst discovery and optimization.

Conflict of Interests

The authors declare no conflict of interest.

Supporting information

Supporting Information

Acknowledgements

The authors are grateful to Dr. Georgi R. Genov for the synthesis of several chiral cations used in this study, Nicholas J. Hodson for preliminary studies relating to in situ ion pairing, and to Dr. Alexander Fanourakis for useful discussions throughout. They are also grateful to Dr. Peter Gierth, Andrew Mason and Duncan J. Howe for assistance in acquiring NMR spectra. Lastly, the authors thank the Dydio group for their assistance with chiral GC analysis. For funding, they are grateful to the Agency for Science, Technology and Research (A*STAR) for a National Science Scholarship (A.R.L), the R&D Center of Mitsui Chemicals, Inc. (S.T.), the European Union for Erasmus + funding (C.Z.), Janssen Research and Development, A Division of Janssen Pharmaceutica NV, Belgium for funding (I.B.) and to the European Research Council under the Horizon 2020 Program (starting grant no. 757381). The authors are grateful to Dr. Carla Obradors (Janssen Research & Development) for useful discussion.

Lit A. R., Takano S., Zachau C., Băltărețu I., Phipps R. J., Angew. Chem. Int. Ed.. 2025, 64, e202507532. 10.1002/anie.202507532

Data Availability Statement

The data that support the findings of this study are available in the Supporting Information of this article.

References

  • 1. Qadir T., Amin A., Sarkar D., Sharma K. P., Curr. Org. Chem. 2021, 25, 1868–1893. [Google Scholar]
  • 2. Dequina H. J., Jones C. L., Schomaker J. M., Chem 2023, 9, 1658–1701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. McCoull W., Davis F. A., Synthesis 2000, 2000, 1347–1365. [Google Scholar]
  • 4. Watson I. D. G., Yu L., Yudin A. K., Acc. Chem. Res. 2006, 39, 194–206. [DOI] [PubMed] [Google Scholar]
  • 5. Stanković S., D'Hooghe M., Catak S., Eum H., Waroquier M., Van Speybroeck V., De Kimpe N., Ha H.‐J., Chem. Soc. Rev. 2012, 41, 643–665. [DOI] [PubMed] [Google Scholar]
  • 6. Callebaut G., Meiresonne T., De Kimpe N., Mangelinckx S., Chem. Rev. 2014, 114, 7954–8015. [DOI] [PubMed] [Google Scholar]
  • 7. Müller P., Fruit C., Chem. Rev. 2003, 103, 2905–2920. [DOI] [PubMed] [Google Scholar]
  • 8. Degennaro L., Trinchera P., Luisi R., Chem. Rev. 2014, 114, 7881–7929. [DOI] [PubMed] [Google Scholar]
  • 9. Pellissier H., Adv. Synth. Catal. 2014, 356, 1899–1935. [Google Scholar]
  • 10. Uchida T., Katsuki T., Chem. Rec. 2014, 14, 117–129. [DOI] [PubMed] [Google Scholar]
  • 11. Roma E., Tosi E., Miceli M., Gasperi T., Asian J. Org. Chem. 2018, 7, 2357–2367. [Google Scholar]
  • 12. Ju M., Schomaker J. M., Nat. Rev. Chem. 2021, 5, 580–594. [DOI] [PubMed] [Google Scholar]
  • 13. Hao G.‐L., Wang J., Mou S.‐B., Luo M.‐P., Teng Q., Wang S.‐G., ChemCatChem 2024, 16, e202400791. [Google Scholar]
  • 14. Sweeney J. B., Chem. Soc. Rev. 2002, 31, 247–258. [DOI] [PubMed] [Google Scholar]
  • 15. Evans D. A., Woerpel K. A., Hinman M. M., Faul M. M., J. Am. Chem. Soc. 1991, 113, 726–728. [Google Scholar]
  • 16. Li Z., Conser K. R., Jacobsen E. N., J. Am. Chem. Soc. 1993, 115, 5326–5327. [Google Scholar]
  • 17. Li Z., Quan R. W., Jacobsen E. N., J. Am. Chem. Soc. 1995, 117, 5889–5890. [Google Scholar]
  • 18. Nishikori H., Katsuki T., Tetrahedron Lett. 1996, 37, 9245–9248. [Google Scholar]
  • 19. Lai T.‐S., Che C.‐M., Kwong H.‐L., Peng S.‐M., Chem. Commun. 1997, 2373–2374. [Google Scholar]
  • 20. Liang J.‐L., Yu X.‐Q., Che C.‐M., Chem. Commun. 2002, 124–125. [DOI] [PubMed] [Google Scholar]
  • 21. Omura K., Uchida T., Irie R., Katsuki T., Chem. Commun. 2004, 2060–2061. [DOI] [PubMed] [Google Scholar]
  • 22. Jones J. E., Ruppel J. V., Gao G.‐Y., Moore T. M., Zhang X. P., J. Org. Chem. 2008, 73, 7260–7265. [DOI] [PubMed] [Google Scholar]
  • 23. Subbarayan V., Ruppel J. V., Zhu S., Perman J. A., Zhang X. P., Chem. Commun. 2009, 4266–4268. [DOI] [PubMed] [Google Scholar]
  • 24. Kim C., Uchida T., Katsuki T., Chem. Commun. 2012, 48, 7188–7190. [DOI] [PubMed] [Google Scholar]
  • 25. Jin L.‐M., Xu X., Lu H., Cui X., Wojtas L., Zhang X. P., Angew. Chem. Int. Ed. 2013, 52, 5309–5313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Chan K.‐H., Guan X., Lo V. K.‐Y., Che C.‐M., Angew. Chem. Int. Ed. 2014, 53, 2982–2987. [DOI] [PubMed] [Google Scholar]
  • 27. Subbarayan V., Jin L.‐M., Cui X., Zhang X. P., Tetrahedron Lett. 2015, 56, 3431–3434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Jiang H., Lang K., Lu H., Wojtas L., Zhang X. P., J. Am. Chem. Soc. 2017, 139, 9164–9167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Riart‐Ferrer X., Sang P., Tao J., Xu H., Jin L.‐M., Lu H., Cui X., Wojtas L., Zhang X. P., Chem 2021, 7, 1120–1134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Hansen K. B., Finney N. S., Jacobsen E. N., Angew. Chem. Int. Ed. Engl. 1995, 34, 676–678. [Google Scholar]
  • 31. Rasmussen K. G., Jørgensen K. A., J. Chem. Soc., Chem. Commun. 1995, 1401–1402. [Google Scholar]
  • 32. Krumper J. R., Gerisch M., Suh J. M., Bergman R. G., Tilley T. D., J. Org. Chem. 2003, 68, 9705–9710. [DOI] [PubMed] [Google Scholar]
  • 33. Ranocchiari M., Mezzetti A., Organometallics 2009, 28, 3611–3613. [Google Scholar]
  • 34. Egloff J., Ranocchiari M., Schira A., Schotes C., Mezzetti A., Organometallics 2013, 32, 4690–4701. [Google Scholar]
  • 35. Farwell C. C., Zhang R. K., McIntosh J. A., Hyster T. K., Arnold F. H., ACS Cent. Sci. 2015, 1, 89–93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Cho I., Prier C. K., Jia Z.‐J., Zhang R. K., Görbe T., Arnold F. H., Angew. Chem. Int. Ed. 2019, 58, 3138–3142. [DOI] [PubMed] [Google Scholar]
  • 37. Boquet V., Nasrallah A., Dana A. L., Brunard E., Di Chenna P. H., Duran F. J., Retailleau P., Darses B., Sircoglou M., Dauban P., J. Am. Chem. Soc. 2022, 144, 17156–17164. [DOI] [PubMed] [Google Scholar]
  • 38. Gross P., Im H., Laws D., III, Park B., Baik M.‐H., Blakey S. B., J. Am. Chem. Soc. 2024, 146, 1447–1454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Wang J., Luo M.‐P., Gu Y.‐J., Liu Y.‐Y., Yin Q., Wang S.‐G., Angew. Chem. Int. Ed. 2024, 63, e202400502. [DOI] [PubMed] [Google Scholar]
  • 40. Katsuki T., Sharpless K. B., J. Am. Chem. Soc. 1980, 102, 5974–5976. [Google Scholar]
  • 41. Gao Y., Klunder J. M., Hanson R. M., Masamune H., Ko S. Y., Sharpless K. B., J. Am. Chem. Soc. 1987, 109, 5765–5780. [Google Scholar]
  • 42. Sharpless K. B., Angew. Chem. Int. Ed. 2002, 41, 2024. [Google Scholar]
  • 43.For Sharpless protocol for racemic aziridination of allylic alcohols, see: Jeong J. U., Tao B., Sagasser I., Henniges H., Sharpless K. B., J. Am. Chem. Soc. 1998, 120, 6844–6845. [Google Scholar]
  • 44. Atkinson R. S., Kelly B. J., J. Chem. Soc., Chem. Commun. 1988, 624–625. [Google Scholar]
  • 45. Coote S. C., O'Brien P., Whitwood A. C., Org. Biomol. Chem. 2008, 6, 4299. [DOI] [PubMed] [Google Scholar]
  • 46. Davies S. G., Ling K. B., Roberts P. M., Russell A. J., Thomson J. E., Woods P. A., Tetrahedron 2010, 66, 6806–6813. [Google Scholar]
  • 47. Zhang Y.‐Q., Bohle F., Bleith R., Schnakenburg G., Grimme S., Gansäuer A., Angew. Chem. Int. Ed. 2018, 57, 13528–13532. [DOI] [PubMed] [Google Scholar]
  • 48. Llaveria J., Beltrán Á., Díaz‐Requejo M. M., Matheu M. I., Castillón S., Pérez P. J., Angew. Chem. Int. Ed. 2010, 49, 7092–7095. [DOI] [PubMed] [Google Scholar]
  • 49. Llaveria J., Beltrán Á., Sameera W. M. C., Locati A., Díaz‐Requejo M. M., Matheu M. I., Castillón S., Maseras F., Pérez P. J., J. Am. Chem. Soc. 2014, 136, 5342–5350. [DOI] [PubMed] [Google Scholar]
  • 50. Berndt J.‐P., Radchenko Y., Becker J., Logemann C., Bhandari D. R., Hrdina R., Schreiner P. R., Chem. Sci. 2019, 10, 3324–3329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Fanourakis A., Williams B. D., Paterson K. J., Phipps R. J., J. Am. Chem. Soc. 2021, 143, 10070–10076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Fanourakis A., Hodson N. J., Lit A. R., Phipps R. J., J. Am. Chem. Soc. 2023, 145, 7516–7527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Hodson N. J., Takano S., Fanourakis A., Phipps R. J., J. Am. Chem. Soc. 2024, 146, 22629–22641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Ager D. J., Prakash I., Schaad D. R., Chem. Rev. 1996, 96, 835–876. [DOI] [PubMed] [Google Scholar]
  • 55. Bergmeier S. C., Tetrahedron 2000, 56, 2561–2576. [Google Scholar]
  • 56. Boumzour W., El Youssfi S., El Hammoumi M. M., Maazouz O., Nassri A., El Bachiri A., J. Mol. Struct. 2025, 1321, 140028. [Google Scholar]
  • 57. Reddy R. P., Davies H. M. L., Org. Lett. 2006, 8, 5013–5016. [DOI] [PubMed] [Google Scholar]
  • 58. Nakafuku K. M., Zhang Z., Wappes E. A., Stateman L. M., Chen A. D., Nagib D. A., Nat. Chem. 2020, 12, 697–704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Wang G., Zhou Z., Shen X., Ivlev S., Meggers E., Chem. Commun. 2020, 56, 7714–7717. [DOI] [PubMed] [Google Scholar]
  • 60. Zhou Z., Tan Y., Shen X., Ivlev S., Meggers E., Sci. China Chem. 2021, 64, 452–458. [Google Scholar]
  • 61. Lang K., Hu Y., Lee W.‐C. C., Zhang X. P., Nature Synthesis 2022, 1, 548–557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Jeong J., Jung H., Kim D., Chang S., ACS Catal. 2022, 12, 8127–8138. [Google Scholar]
  • 63. Majhi J., Roy S., Chattopadhyay A., Fasan R., ACS Catal. 2025, 15, 809–816. [Google Scholar]
  • 64. Dai L., Chen Y.‐Y., Xiao L.‐J., Zhou Q.‐L., Angew. Chem. Int. Ed. 2023, 62, e202304427. [DOI] [PubMed] [Google Scholar]
  • 65. Paterson K. J., Dahiya A., Williams B. D., Phipps R. J., Angew. Chem. Int. Ed. 2024, 63, e202317489. [DOI] [PubMed] [Google Scholar]
  • 66. O'Brien P., Angew. Chem. Int. Ed. 1999, 38, 326–329. [DOI] [PubMed] [Google Scholar]
  • 67. Nilov D., Reiser O., Adv. Synth. Catal. 2002, 344, 1169–1173. [Google Scholar]
  • 68. Williamson K. S., Yoon T. P., J. Am. Chem. Soc. 2012, 134, 12370–12373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Liu G.‐S., Zhang Y.‐Q., Yuan Y.‐A., Xu H., J. Am. Chem. Soc. 2013, 135, 3343–3346. [DOI] [PubMed] [Google Scholar]
  • 70. Lu D.‐F., Zhu C.‐L., Jia Z.‐X., Xu H., J. Am. Chem. Soc. 2014, 136, 13186–13189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71. Zhu R., Buchwald S. L., J. Am. Chem. Soc. 2015, 137, 8069–8077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72. Tan Y., Han F., Hemming M., Wang J., Harms K., Xie X., Meggers E., Org. Lett. 2020, 22, 6653–6656. [DOI] [PubMed] [Google Scholar]
  • 73. Kim S., Kim D., Hong S. Y., Chang S., J. Am. Chem. Soc. 2021, 143, 3993–4004. [DOI] [PubMed] [Google Scholar]
  • 74. Mumford E. M., Hemric B. N., Denmark S. E., J. Am. Chem. Soc. 2021, 143, 13408–13417. [DOI] [PubMed] [Google Scholar]
  • 75. Wata C., Hashimoto T., J. Am. Chem. Soc. 2021, 143, 1745–1751. [DOI] [PubMed] [Google Scholar]
  • 76. Nie X., Ritter C. W., Hemming M., Ivlev S. I., Xie X., Chen S., Meggers E., Angew. Chem. Int. Ed. 2023, 62, e202314398. [DOI] [PubMed] [Google Scholar]
  • 77. Huang N., Luo J., Liao L., Zhao X., J. Am. Chem. Soc. 2024, 146, 7029–7038. [DOI] [PubMed] [Google Scholar]
  • 78. In some previous studies we obtained slightly improved performance if the Rh complex is added as a bis‐pyridine ligate, the origin of which is still unclear ‐ see ref 52.
  • 79. Matsushima Y., Orita M., Tetrahedron Lett. 2021, 73, 153095. [Google Scholar]
  • 80. Hunter C. A., Angew. Chem. Int. Ed. 2004, 43, 5310–5324. [DOI] [PubMed] [Google Scholar]
  • 81. Collet F., Lescot C., Dauban P., Chem. Soc. Rev. 2011, 40, 1926–1936. [DOI] [PubMed] [Google Scholar]
  • 82. Hayashi H., Uchida T., Eur. J. Org. Chem. 2020, 2020, 909–916. [Google Scholar]
  • 83. Fanourakis A., Phipps R. J., Chem. Sci. 2023, 14, 12447–12476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84. Müller P., Baud C., Jacquier Y., Moran M., Nägeli I., J. Phys. Org. Chem. 1996, 9, 341–347. [Google Scholar]
  • 85. Nägeli I., Baud C., Bernardinelli G., Jacquier Y., Moraon M., Müller P., Helv. Chim. Act. 1997, 80, 1087–1105. [Google Scholar]
  • 86. Yamawaki M., Tsutsui H., Kitagaki S., Anada M., Hashimoto S., Tetrahedron Lett. 2002, 43, 9561–9564. [Google Scholar]
  • 87. Fruit C., Müller P., Helv. Chim. Act. 2004, 87, 1607–1615. [Google Scholar]
  • 88. Milczek E., Boudet N., Blakey S., Angew. Chem. Int. Ed. 2008, 47, 6825–6828. [DOI] [PubMed] [Google Scholar]
  • 89. Zalatan D. N., Bois J. D.u, J. Am. Chem. Soc. 2008, 130, 9220–9221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90. Höke T., Herdtweck E., Bach T., Chem. Commun. 2013, 49, 8009–8011. [DOI] [PubMed] [Google Scholar]
  • 91. Nasrallah A., Boquet V., Hecker A., Retailleau P., Darses B., Dauban P., Angew. Chem. Int. Ed. 2019, 58, 8192–8196. [DOI] [PubMed] [Google Scholar]
  • 92. Nasrallah A., Lazib Y., Boquet V., Darses B., Dauban P., Org. Proc. Res. Dev. 2020, 24, 724–728. [Google Scholar]
  • 93. van den Heuvel N., Mason S. M., Mercado B. Q., Miller S. J., J. Am. Chem. Soc. 2023, 145, 12377–12385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94. Brunard E., Boquet V., Saget T., Sosa Carrizo E. D., Sircoglou M., Dauban P., J. Am. Chem. Soc. 2024, 146, 5843–5854. [DOI] [PubMed] [Google Scholar]
  • 95. Chiappini N. D., Mack J. B. C., Du Bois J., Angew. Chem. Int. Ed. 2018, 57, 4956–4959. [DOI] [PubMed] [Google Scholar]
  • 96. Shirakawa S., Kasai A., Tokuda T., Maruoka K., Chem. Sci. 2013, 4, 2248. [Google Scholar]
  • 97. He R., Shirakawa S., Maruoka K., J. Am. Chem. Soc. 2009, 131, 16620–16621. [DOI] [PubMed] [Google Scholar]
  • 98. Ohmatsu K., Hara Y., Ooi T., Chem. Sci. 2014, 5, 3645–3650. [Google Scholar]
  • 99. Wagen C. C., McMinn S. E., Kwan E. E., Jacobsen E. N., Nature 2022, 610, 680–686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100. Korch K. M., Hayes J. C., Kim R. S., Sampson J., Kelly A. T., Watson D. A., ACS Catal. 2022, 12, 6737–6745. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

Data Availability Statement

The data that support the findings of this study are available in the Supporting Information of this article.


Articles from Angewandte Chemie (International Ed. in English) are provided here courtesy of Wiley

RESOURCES